Premier Asset Management LLC Amarin Corp Plcuk Transaction History

Premier Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$3.94 - $5.84 $76,830 - $113,880	19,500 New	19,500 $99,000
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $133,362 - $284,310	-36,638 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$4.78 - $8.26 $175,129 - $302,629	36,638 New	36,638 $254,000
Q1 2020 May 07, 2020	SELL	$4.0 - $21.53 $105,384 - $567,229	-26,346 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$13.94 - $24.12 $367,263 - $635,465	26,346 New	26,346 $565,000
Q3 2019 Nov 01, 2019	SELL	$13.89 - $23.16 $393,253 - $655,705	-28,312 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$16.27 - $20.51 $460,636 - $580,679	28,312 New	28,312 $548,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $214M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Premier Asset Management LLC with notifications on news.